CHICAGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Amplify ETFs announces the realignment of its cannabis ETFs to provide investors with dynamic exposure to the cannabis industry. On January 28, 2025, the Amplify Seymour Cannabis ETF (CNBS) will change its investment policy to invest in securities of U.S. companies engaged in cannabis and hemp-related activities. In addition, the Amplify Alternative Harvest ETF (MJ) will allocate to CNBS to gain exposure to U.S. cannabis companies following an index methodology change.

The move reflects Amplify ETFs’ commitment to refining its product suite for investors. Through the changes, MJ will continue to offer access to the global cannabis industry, now gaining its U.S. exposure through an allocation to CNBS within the index.

“The cannabis industry is an evolving market, and we recognized an exceptional opportunity to leverage the expertise of one of its foremost authorities, Tim Seymour. By doing so, we’ve positioned ourselves to enhance offerings and create what we believe is a competitive advantage,” said Christian Magoon, CEO of Amplify ETFs.

By utilizing CNBS for its U.S. exposure, MJ provides a seamless and diversified investment strategy, representing global and domestic cannabis opportunities in one ETF.

CNBS is an actively managed cannabis ETF, which launched in July 2019. Tim Seymour, CIO of Seymour Asset Management and portfolio manager for CNBS, will refine CNBS’ focus primarily on U.S. companies principally engaged in the emerging cannabis and hemp ecosystem. CNBS targets three classifications: cannabis/hemp plant operations, support cultivation and retail, and ancillary companies providing services and products to the cannabis market. At least 80% of its portfolio companies derive more than 50% of their revenue from cannabis and hemp-related activities.

Seymour employs a rigorous blend of top-down and bottom-up analysis to identify opportunities, utilizing macroeconomic data, regulatory filings, third-party research, and ESG scoring. He added, “CNBS is uniquely positioned to capitalize on opportunities in the U.S. cannabis market through our active management strategy, and we view the US cannabis industry as the largest addressable market for sourcing cannabis investments. We seek exposure to the companies that are executing today and are well positioned for tomorrow’s growth. We believe the integration of CNBS into MJ’s methodology enhances investor access to a dynamic and growing sector and look forward to working closely with Prime Indexes, who founded the MJ reference index.”

Additionally, MJ and CNBS will each participate in a reverse share split ratio of 1 for 12. The reverse splits will be effective on February 21, 2025, and the funds will then begin trading at their post-split prices. The respective ticker symbols will not change, but each fund will be issued with new CUSIP numbers as listed below.

The reverse splits will increase the price per share of each fund, with a proportionate decrease in the number of shares outstanding. For a one-for-twelve reverse split, every twelve pre-split shares will result in the receipt of one post-split share, which will be priced twelve times higher than the NAV of a pre-split share.

About Amplify ETFs
Amplify ETFs, sponsored by Amplify Investments, has over $10.4 billion in assets across its suite of ETFs (as of 01/21/2025). Amplify ETFs delivers expanded investment opportunities for investors seeking growth, income, and risk-managed strategies across a range of actively managed and index-based ETFs. To learn more visit AmplifyETFs.com.

Carefully consider the Fund’s investment objectives, risks, charges, and expenses before investing. This and other information can be found in the Fund’s statutory and summary prospectuses, which may be obtained at AmplifyETFs.com. Read the prospectus carefully before investing.

Investing involves risk, including the possible loss of principal. Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV and are not individually redeemed from the Fund. Brokerage commissions will reduce returns.

Narrowly focused investments typically exhibit higher volatility. Companies involved in the cannabis industry face competition, may have limited access to the services of banks, may have substantial burdens on company resources due to litigation, complaints or enforcement actions, and are heavily dependent on receiving necessary permits and authorizations to engage in medical cannabis research or to otherwise cultivate, possess or distribute cannabis. The possession and use of cannabis, even for medical purposes, is illegal under federal and certain states’ laws, which may negatively impact the value of the Fund’s investments. Securities issued by non-U.S. companies present risks beyond those of securities of U.S. issuers. Small and/or mid-capitalization companies may be more vulnerable to adverse general market or economic developments, and their securities may be less liquid and may experience greater price volatility than large-cap companies. The Fund is non-diversified, which can cause greater share price fluctuation.

CNBS is actively managed and subject to management risk. MJ is a passive ETF that seeks to replicate the performance of a designated index by holding the assets listed on the index. Passive ETFs are subject to total market risk and lack flexibility.

Amplify Investments LLC is the Investment Adviser to the Funds. Seymour Asset Management LLC and Tidal Investments, LLC serves as the Investment Sub-Advisers for the Funds.

Amplify ETFs are distributed by Foreside Fund Services, LLC.